Trimethoprim-sulfamethoxazole (1.25+23.75) SXT 25 µg
by Liofilchem S.r.l. 3 variants
Ref 9042/2
Active
CE IVDR
Valid until
Not listed
FDA recalls
Not applicable
Documents
None linked in EUDAMED
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR | Number805518287ATBDISC042YL 18055182875303 | Date20 Oct 2026 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDR Active
Specification
- Device Name
- Trimethoprim-sulfamethoxazole (1.25+23.75) SXT 25 µg
- Model / Reference
- 9042/2
- Primary DI / UDI-DI
- 18055182875303
- Basic UDI-DI
- 805518287ATBDISC042YL
- EMDN Code
- W0104080502 Impregnated disks, multi-disks & tablets
- Device Class
- Class B
- EU market of registration
- Italy
Manufacturer details
- EUDAMED SRN
- IT-MF-000026495
Other devices from Liofilchem S.r.l.
Properties
Other properties (9)
- Sterile: No
- Human Tissues: No
- Microbial Substances: No
- Reagent: No
- Self Testing: No
- Near-Patient Testing: No
- Companion Diagnostics: No
- Surgical Instrument: No
- New Device: No